The average one-year price target for Vor Biopharma (NasdaqGS:VOR) has been revised to $47.68 / share. This is an increase of ...
TipRanks on MSN
Vor Biopharma Unveils Promising Phase 3 Trial Results
Vor Biopharma ( (VOR) ) has provided an update. On October 28, 2025, Vor Biopharma Inc. hosted a webcast to present 48-week Phase 3 clinical trial data from China for telitacicept in treating primary ...
In what has been described as a scene from a mafia movie, a journalist in Brooklyn, New York, narrowly escaped being ...
Telitacicept delivered consistent quality-of-life improvement across both treatment and placebo crossover arms 100% of ...
Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're ...
A British family`s delightful reaction to Indian ginger tea on the Vande Bharat Express goes viral! See their surprise and ...
Noida: Directorate General of Civil Aviation (DGCA) will oversee calibration flights at Noida International Airport (NIA) on ...
Masih Alinejad, an Iranian-American journalist critical of Iran, was 'chillingly close' to being murdered, the Justice ...
RICHMOND HILL, ON, Oct. 27, 2025 /CNW/ — Compugen Inc., the largest Canadian-owned Technology Ally, is excited to announce the successful award of all technology categories under the Supply Ontario ...
As a growing number of Americans approach retirement, many still have not fully considered how inflation and ...
Cincinnati Financial Corp (NASDAQ:CINF) Director Dirk J. Debbink purchased 1,000 shares of common stock at $153.98 per share on October 28, 2025, for a total investment of $153,980. The transaction, ...
Alinejad is a fervent critic of the Iranian government and its morality police, which prosecutors say “enraged the regime.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results